CA1255399A - Implants interstitiel emettant des rayons x - Google Patents
Implants interstitiel emettant des rayons xInfo
- Publication number
- CA1255399A CA1255399A CA000500879A CA500879A CA1255399A CA 1255399 A CA1255399 A CA 1255399A CA 000500879 A CA000500879 A CA 000500879A CA 500879 A CA500879 A CA 500879A CA 1255399 A CA1255399 A CA 1255399A
- Authority
- CA
- Canada
- Prior art keywords
- palladium
- seed
- tubular member
- ray
- radiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000007943 implant Substances 0.000 title abstract description 9
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims abstract description 170
- 229910052763 palladium Inorganic materials 0.000 claims abstract description 85
- 239000000463 material Substances 0.000 claims abstract description 82
- KDLHZDBZIXYQEI-OIOBTWANSA-N palladium-103 Chemical compound [103Pd] KDLHZDBZIXYQEI-OIOBTWANSA-N 0.000 claims abstract description 74
- 230000005855 radiation Effects 0.000 claims abstract description 63
- 239000003550 marker Substances 0.000 claims abstract description 44
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 31
- 230000004907 flux Effects 0.000 claims abstract description 24
- 239000002245 particle Substances 0.000 claims abstract description 23
- 238000002513 implantation Methods 0.000 claims abstract description 18
- 238000009826 distribution Methods 0.000 claims abstract description 12
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229910052703 rhodium Inorganic materials 0.000 claims abstract description 8
- 239000010948 rhodium Substances 0.000 claims abstract description 8
- 238000012800 visualization Methods 0.000 claims abstract description 7
- 239000008188 pellet Substances 0.000 claims description 50
- 238000000034 method Methods 0.000 claims description 30
- 230000002285 radioactive effect Effects 0.000 claims description 23
- 239000011133 lead Substances 0.000 claims description 14
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 13
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 12
- 239000010936 titanium Substances 0.000 claims description 12
- 229910052719 titanium Inorganic materials 0.000 claims description 12
- 239000012535 impurity Substances 0.000 claims description 11
- 230000008878 coupling Effects 0.000 claims description 10
- 238000010168 coupling process Methods 0.000 claims description 10
- 238000005859 coupling reaction Methods 0.000 claims description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 8
- 239000012857 radioactive material Substances 0.000 claims description 8
- 238000001228 spectrum Methods 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 6
- 230000003213 activating effect Effects 0.000 claims description 4
- 239000000560 biocompatible material Substances 0.000 claims description 4
- 229910052742 iron Inorganic materials 0.000 claims description 4
- 210000001124 body fluid Anatomy 0.000 claims description 3
- 238000010276 construction Methods 0.000 abstract description 16
- 238000003466 welding Methods 0.000 abstract description 11
- 239000011257 shell material Substances 0.000 description 37
- 239000002775 capsule Substances 0.000 description 27
- 230000008901 benefit Effects 0.000 description 22
- 230000000694 effects Effects 0.000 description 21
- PNDPGZBMCMUPRI-XXSWNUTMSA-N [125I][125I] Chemical compound [125I][125I] PNDPGZBMCMUPRI-XXSWNUTMSA-N 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 13
- 230000008569 process Effects 0.000 description 13
- 210000001519 tissue Anatomy 0.000 description 13
- 229940044173 iodine-125 Drugs 0.000 description 11
- 230000004913 activation Effects 0.000 description 10
- 238000003780 insertion Methods 0.000 description 9
- 230000037431 insertion Effects 0.000 description 9
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 8
- 229910052782 aluminium Inorganic materials 0.000 description 8
- 239000011324 bead Substances 0.000 description 8
- 239000011630 iodine Substances 0.000 description 8
- 229910052740 iodine Inorganic materials 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 206010073306 Exposure to radiation Diseases 0.000 description 5
- 229910052737 gold Inorganic materials 0.000 description 5
- 239000010931 gold Substances 0.000 description 5
- 238000009377 nuclear transmutation Methods 0.000 description 5
- 125000006850 spacer group Chemical group 0.000 description 5
- 239000000956 alloy Substances 0.000 description 4
- 229910045601 alloy Inorganic materials 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 230000002238 attenuated effect Effects 0.000 description 3
- PCHJSUWPFVWCPO-OUBTZVSYSA-N gold-198 Chemical compound [198Au] PCHJSUWPFVWCPO-OUBTZVSYSA-N 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- SYUHGPGVQRZVTB-UHFFFAOYSA-N radon atom Chemical compound [Rn] SYUHGPGVQRZVTB-UHFFFAOYSA-N 0.000 description 3
- 230000007420 reactivation Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 3
- 229910052721 tungsten Inorganic materials 0.000 description 3
- 239000010937 tungsten Substances 0.000 description 3
- 230000009471 action Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 238000009388 chemical precipitation Methods 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229910052741 iridium Inorganic materials 0.000 description 2
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 101100008049 Caenorhabditis elegans cut-5 gene Proteins 0.000 description 1
- 241001307210 Pene Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 231100000569 acute exposure Toxicity 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000004323 axial length Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000002725 brachytherapy Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- TVFDJXOCXUVLDH-YPZZEJLDSA-N cesium-131 Chemical compound [131Cs] TVFDJXOCXUVLDH-YPZZEJLDSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940071829 ilaris Drugs 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- GKOZUEZYRPOHIO-IGMARMGPSA-N iridium-192 Chemical compound [192Ir] GKOZUEZYRPOHIO-IGMARMGPSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000005355 lead glass Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- HBEQXAKJSGXAIQ-UHFFFAOYSA-N oxopalladium Chemical compound [Pd]=O HBEQXAKJSGXAIQ-UHFFFAOYSA-N 0.000 description 1
- 150000002941 palladium compounds Chemical class 0.000 description 1
- 229910003445 palladium oxide Inorganic materials 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000005258 radioactive decay Effects 0.000 description 1
- 230000000693 radiobiological effect Effects 0.000 description 1
- 239000011819 refractory material Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000007794 visualization technique Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 238000004846 x-ray emission Methods 0.000 description 1
Landscapes
- Radiation-Therapy Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000500879A CA1255399A (fr) | 1986-01-31 | 1986-01-31 | Implants interstitiel emettant des rayons x |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000500879A CA1255399A (fr) | 1986-01-31 | 1986-01-31 | Implants interstitiel emettant des rayons x |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1255399A true CA1255399A (fr) | 1989-06-06 |
Family
ID=4132396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000500879A Expired CA1255399A (fr) | 1986-01-31 | 1986-01-31 | Implants interstitiel emettant des rayons x |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA1255399A (fr) |
-
1986
- 1986-01-31 CA CA000500879A patent/CA1255399A/fr not_active Expired
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0210269B1 (fr) | Implantations interstitielles avec emission de rayons x | |
| US6986880B2 (en) | Polymeric-matrix brachytherapy sources | |
| US3351049A (en) | Therapeutic metal seed containing within a radioactive isotope disposed on a carrier and method of manufacture | |
| CA2370532C (fr) | Enveloppe pour grain radioactif | |
| EP1149389B1 (fr) | Grains de curietherapie ameliores | |
| US6471630B1 (en) | Transmutable radiotherapy device | |
| WO1997019706A9 (fr) | Radio-isotope disperse dans une matrice destine a la curietherapie | |
| US10646724B2 (en) | Brachytherapy devices and related methods having microencapsulated brachytherapy materials | |
| AU7253998A (en) | Combination radioactive and temperature self-regulating thermal seed implant for treating tumors | |
| US7530941B2 (en) | X-ray and gamma ray emitting temporary high dose rate brachytherapy source | |
| US20080004483A1 (en) | Biodegradable seed placement device and method | |
| US6770019B1 (en) | Radiation source for endovascular radiation treatment in form of a wire | |
| US6400796B1 (en) | X-ray emitting sources and uses thereof | |
| Coursey et al. | Radionuclide therapy | |
| EP1232771B1 (fr) | Capsule radioactive | |
| CA1255399A (fr) | Implants interstitiel emettant des rayons x | |
| WO2000059571A2 (fr) | Procede et dispositif de curietherapie | |
| CN213527173U (zh) | 一种近距离放射治疗碘-125粒子链及源仓 | |
| CA2010038A1 (fr) | Dispositifs de radiotherapie a faible energie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |